Financial costs, benefits, and patient risk preferences in node-negative breast cancer: insights from a decision analysis model.
Hillner
B E
BE
Department of Internal Medicine, Medical College of Virginia, Virginia Commonwealth University, Richmond 23298-0170.
D001943:Breast Neoplasms / Q000188:drug therapy* / Q000191:economics; D017024:Chemotherapy, Adjuvant / Q000191:economics; D003362:Cost-Benefit Analysis; D003661:Decision Support Techniques; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008390:Markov Chains; D008875:Middle Aged; D012306:Risk